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Regulation of Genes related to Lipid Metabolism in Atlantic 
salmon (Salmo salar L.). In Vitro and In Vivo Studies 
Abstract 
Fish is a vital source of highly valuable omega-3 (n-3) fatty acids (FA) in the human 
diet. With declining commercial fisheries, aquaculture fish constitute a growing 
proportion in human consumption. Sustainable development of aquaculture dictates 
that the fish feed used not solely is based on fish oil (FO) but also contain increasing 
levels of vegetable oil (VO). The replacement of FO with VO influences FA 
composition in fish tissues with the decrease of the n-3 highly unsaturated fatty acids 
(HUFAs), as main consequence rendering a fish less beneficial for human health. 
Accordingly the last decade of salmonid research has been focusing on increasing the 
amount of HUFAs in fish fed VO diets. Part of this focus has been on the addition of 
bioactive compounds to VO diets. In this thesis 2 studies are presented trying to shed 
more light on the potential positive effects of bioactive compounds. 
Paper I examine in vivo the effects of sesamin inclusion on Atlantic salmon (Salmo 
salar L.) fed VO-based diets with different n-6/n-3 FA ratios. Fish were fed for 4 
months. In Paper II in vitro effects of bioactive compounds (genistein, lipoic acid, 
sesamin/episesamin and sesamin) were investigated in Atlantic salmon primary 
hepatocytes. Analyses were made 12h and 48h after addition of bioactive compounds, 
with most effects seen after 48h. In both studies, the FA composition and expression of 
genes involved in transcription, lipid uptake, desaturation, elongation and β-oxidation 
were examined.  
Genes involved in transcription regulation, β-oxidation, elongation and desaturation 
were affected by addition of bioactive compounds in both in vivo and in vitro 
experiments. Effects on the FA composition were found, but no clear affect on the 
DHA content. High level of sesamin supplementation had negative effect on growth 
rate and live weight.  
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Abbreviations 
ARA Arachidonic acid (20:4 n-6) 
ACO Acyl-CoA oxidase 
ALA α-linolenic acid (18:3n-3) 
bp Base pair 
CD36 Cluster of differentiation 36 
CPT1 Carnitine palmitoyltransferase 1 
Δ5FAD Delta 5 fatty acid desaturase 
Δ6FAD Delta 6 fatty acid desaturase 
DHA Docosahexaenoic acid (22:6 n-3) 
DPA Docosapentaenoic acid (22:5n-3) 
DTA Dodecylthioacetic acid 
ELOVL Elongase of very long chain fatty acids (four different transcripts) 
EPA Eicosapentaenoic acid (20:5n-3) 
EF1α Elongation factor 1a  
ETiF Eukaryotic translation initiation factor 3 
ER Endoplasmic reticulum 
ES Episesamin 
FA Fatty acid 
FO Fish oil 
G Genistein 
HUFA Highly unsaturated fatty acid, here in this thesis defined as PUFAs 
constituting of 20 or more carbon molecules with at least three 
double bonds (equivalent to LCPUFA) 
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1 Introduction 
In recent years, there has been increased focus on the role of dietary fatty acids 
(FA) on human health and disease.  
To simplify basically, two families of FA are needed to be present in 
adequate and balanced quantities within the human body for man to stay 
healthy. These two groups of FA are the omega-6 (n-6) and omega-3 (n-3) 
polyunsaturated fatty acids (PUFA).  
Meeting the dietary demands of a growing human population for balanced 
PUFA intake, and at levels required for normal health and development, is a 
major challenge. One way to meet this demand is through aquaculture of fish, 
such as salmon, tuna, sardines, cod, mackerel, and trout that all contain high 
levels of n-3 long chain polyunsaturated fatty acids (LCPUFA) and are low in 
n-6 FAs. Both these factors are clearly beneficial for human health 
(Simopoulos, 2002; Horrocks & Yeo, 1999; Simopoulos, 1999a; Kyle & 
Arterburn, 1998). 
However, aquaculture is a sensitive to both economical as well as 
environmental influences (Tacon & Metian, 2009). To understand how such 
influences affect the outcome of aquaculture including physical condition of 
the fish and beneficial effects for human health is therefore of importance. One 
way to achieve a better understanding of the regulation of the PUFA 
metabolism is to monitor the underlying internal molecular mechanisms.  
1.1 Lipids & Fatty acids 
Lipids are a diverse group of compounds that are classified together on the 
basis of their insolubility in water. Roughly we can talk about two classes of 
lipids – neutral and polar lipids. Neutral lipids primarily include 
triacylglycerols (TAG), diacylglycerols, monoacylglycerols and sterols, which 
mostly serve as storage and sources of energy. Neutral lipid composition, 
particularly TAG, reflect changes made in the dietary FA composition (Olsen 
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et al., 1991). Polar lipids are mainly phospholipids (PL) that predominantly are 
incorporated into membrane structures. PL also reflect the PUFA composition 
of the diet, but shorter PUFA such as ALA and LA are normally extensively 
elongated and desaturated prior to incorporation into PL (Olsen et al., 1991). 
Fatty acids with one double bond are called monounsaturated fatty acids 
(MUFA), while fatty acids containing two or more double bonds are called 
PUFA. 
1.1.1 Polyunsaturated fatty acids 
In PUFA, the position of the first double bond in relation to the methyl end of 
the carbon chain is of importance for the nomenclature. If the first double bond 
is present next to the third carbon atom from the methyl end, the FA is 
classified as an n-3 FA, while if it is on the sixth carbon atom the FA is termed 
n-6 FA.  
 
Figure 1 Chemical structure of polyunsaturated fatty acids – A. α-linolenic acid (18:3n-3) and B. 
Linoleic acid (18:2n-6) C. Eicosapentaenoic acid (20:5n-3); D. Arachidonic acid (20:4n-6) and E. 
Docosahexaenoic acid (22:6n-3) 
Of the n-6 and n-3 FAs, are two classified as essential, since they cannot be 
synthesized in higher vertebrates including humans and are vital to human 
health - α-linolenic acid (ALA, 18:3n-3), the key essential n-3 FA, and linoleic 
acid (LA, 18:2n-6), the corresponding essential n-6 FA (Figure 1A & 1B). 
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These essential FA can be found in many different sources of food, especially 
in nuts, various plant seeds and oils.  
In the body, LA can be metabolized to its longer chain derivate, arachidonic 
acid (ARA, 20:4 n-6) (Figure 1D), and ALA can be metabolized to 
eicosapentaenoic acid (EPA, 20:5n-3) and further on to docosahexaenoic acid 
(DHA, 22:6 n-3) (Figure 1C & 1E).  
However, in most vertebrates, the ALA conversion to EPA or DHA is very 
limited. Fish and shellfish being naturally high in EPA and DHA are without 
doubt the most important source for the highly unsaturated n-3 fatty acids 
(HUFA). Furthermore, fish is naturally low in n-6 FA and consequently 
therefore generate a low n-6/n-3 ratio, which is known to be beneficial for 
human health (Simopoulos, 2002; Horrocks & Yeo, 1999; Simopoulos, 1999a; 
Kyle & Arterburn, 1998).  
1.2 Health effects of n-3 fatty acids 
The dietary balance of n-6 and n-3 FA is important for homeostasis and normal 
development in humans (Simopoulos, 2000). Simopoulos (1999b) together 
with Kyle & Arterburn (1998) stressed towards the end of the 1990ties, the 
need to increase the n-3 FA within the human diet. By doing so man would  
return to pre-industrial period intake levels and thereby reduce the risk of many 
diseases, such as arteriosclerosis, coronary heart disease, inflammatory 
diseases and possibly behavioural disorders (Connor, 2000; Horrocks & Yeo, 
1999).  
Besides the role as preventer of many of our most common causes of death, 
the essential FAs, LA and ALA, plus especially their longer chain derivates 
(EPA and DHA), are important components of cell membranes (De Wilde et 
al., 2002; Stauffer, 1996). The functionality of cell membranes specifically the 
fluidity, is vital. The membrane fluidity is dependent on the ratio of different 
FAs, in particular the n-3 and n-6 PUFA. In turn the ratio of these n-3 and n-6 
PUFA is determined by dietary intake (Cartwright et al., 1985). 
Changes to the dietary n-6/n-3 ratio effectively modify the fluidity of 
phospholipid membranes (Jumpsen et al., 1997). As can be seen from Figure 
1C and 1E n-3 PUFAs such as EPA and DHA have a natural curved shape, 
allowing gaps between molecules when incorporated into cell membranes. 
These gaps increase the fluidity of the membrane allowing ion channels to 
undergo conformational change and subsequent membrane fusion to occur, 
enabling cell-to-cell communication (Singer & Nicolson, 1972). In contrast, n-
6 PUFAs (Figure 1D) are straighter and narrower and are therefore reducing 
the number of gaps present in the membrane leading to a decrease in the 
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fluidity. As a result here of, the membranes are less flexible and can potentially 
cause signal conductance problems (Lapillonne et al., 2003). 
In particular, high concentration of DHA is important in neuronal 
membranes. DHA constitutes more than 30% of the total phospholipid 
composition of plasma membranes in the brain and is taken up by the brain in 
preference to other FA (De Wilde et al., 2002). DHA is crucial for maintaining 
membrane integrity and, consequently, neuronal excitability, synaptic function 
and cognitive abilities by making plasma membrane more fluid at synaptic 
regions. Besides DHA, both EPA and ARA are important for normal brain and 
nerve development (Gómez-Pinilla, 2008).  
The n-6 and n-3 FA are metabolically and functionally distinct and have 
opposite physiological effects.  The three PUFAs play an important role as 
precursors for eicosanoids - highly biologically active paracrine hormones 
(Sargent et al., 1999). Generally, eicosanoids are produced in response to 
different kinds of stress. The n-6 PUFAs and their conversion products favor 
immune and inflammatory reactions. The major precursor of eicosanoids is 
ARA whereas those formed from EPA are less biologically active. EPA 
competitively inhibits the formation and actions of eicosanoids formed from 
ARA. The n-3 PUFA remove metabolic fuel from storage towards oxidation 
and are involved in anti-inflammatory reactions (Price et al., 2000). 
1.3 Aquaculture  
1.3.1 From global fisheries to aquaculture 
Meeting the dietary demands of a growing global population for a correct 
dietary balance of PUFAs is a major challenge in which a sustainable 
aquaculture plays an important role. 
Global production of fish from aquaculture has grown substantially with 
~10% per year over the past decades (Sargent, 2001), reaching 52.5 million 
tonnes in 2008, compared with 32.4 million tonnes in 2000. Roughly 50% of 
fish used for human consumption are now farmed and, with global fisheries 
generally in decline (FAO, 2010) and the continues growth of the global 
human population, this proportion is increasing.  
In developed countries, aquaculture largely focuses on carnivorous species 
(e.g., salmon, bluefin tuna and sea bass). Norway and Chile are the world’s 
leading aquaculture producers of salmonids, accounting for 36.4 and 28.0 
percent of world production (1.5 million tonnes), respectively (FAO, 2010). 
The growth in aquaculture was made possible by the development of 
formulated fish feed including amino acids, FAs, minerals and vitamins 
fulfilling all essential requirements. The diets have traditionally been relaying 
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on fish meal and fish oil (FO) rich in n-3 HUFAs from natural fisheries to 
generate a diet high in both lipids and proteins promoting a cost-efficient fish 
growth. The amount of FO consumed in the aquaculture sector has grown 
threefold since 1992 and today around 90% of all FO produced goes to 
aquafeeds (Tacon, 2005). Accordingly, the development of aquaculture has 
been heavily depending on the availability of FO supply as the sole lipid source 
for aquafeeds. FO is made primarily from small pelagic fish such as sardines 
and anchovies, naturally high in both EPA and DHA (Regost et al., 2004). 
However the landings from global fisheries of pelagic fish cannot keep up with 
this increasing demand from the industrial aquaculture. It is therefore of 
importance to find a sustainable alternative to FO as lipid source in fish feed. 
Consequently, this has been one of the main concerns for the aquaculture 
industry during the last decade. 
1.3.2 Reduction of fish oil in fish feeds 
Mainly three different actions have been undertaken to reduce the amount of 
FO used in fish feed and still render satisfactory levels of EPA and DHA. First 
of all, FO has fully or partly been exchanged with VOs naturally high in ALA 
or stearoidonic acid (18:4n-3) and low in LA. Secondly, bioactive compounds 
have been used to promote the ability of fish to convert ALA to EPA and DHA 
(Trattner et al., 2008a; Kennedy et al., 2007a; Kleveland et al., 2006a). Finally, 
selective breeding for heritable traits associated with EPA and DHA 
composition has been evaluated (Leaver et al., 2011; Olesen et al., 2003; 
Gjedrem, 1997). This thesis will focus on the use of bioactive compounds as a 
supplement to VO diets to counteract the decrease in n-3 LCPUFA seen in the 
fish tissues.  
Vegetable oils in fish feed 
In parallel to the growing aquaculture production, the global production of 
fishmeal and FO remains stable or even decline. Due to this shortage of FO, an 
increase in aquaculture production, and the need for alternative sustainable oil 
resources in fish feeds, FO has increasingly been replaced by vegetable oils 
(VO) (Powell, 2003; Thomassen & Røsjø, 1989). In 1997 the acute lack of 
fish-based raw materials, as a result of the weather phenomenon, El Niño in the 
tropical parts of the Pacific Ocean, escalated the search for alternatives to FO. 
At this point the industry started to replace some of the FO in salmon feed with 
VO on a more permanent basis (FAO, 2008; Tacon, 2005). Research has as a 
result of this been focusing on how the replacement of the FO in aquafeeds 
with increasing amounts of VO has influenced the growth and health of the 
cultivated fish.  
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Studies have shown that VO to a great extent can replace FO in fish feed 
without compromising growth, flesh astaxanthin levels or mortality rate 
(Sanden et al., 2011; Torstensen et al., 2005; Bell et al., 2003; Rosenlund, 
2001; Ruyter & Thomassen, 1999). The taste of salmon is known to vary, 
depending on the composition of the salmon feed. However, sensory analyses 
have show that fillets from salmon fed a mixture of VO have roughly the same 
taste and aroma as fillets from salmon whose feed has included FO, but with a 
somewhat less characteristic marine taste and aroma (Sanden et al., 2011; 
Torstensen et al., 2005). 
However, the tissue FA composition has been shown to be highly subjective 
to differences in diet lipid composition (Torstensen et al., 2000; Tocher & 
Dick, 1990). Some VO, such as linseed oil, has a naturally high content of n-3 
ALA. These VO can provide a potentially good substrate for the production of 
EPA and DHA. In order to ensure that the level of saturated, MUFAs and 
PUFAs in VO based feed is at roughly the same level as in FO-based feed, a 
mixture of LO, rape seed oil and palm oil can be used (instead of a single VO) 
(Torstensen et al., 2005). By introducing a finishing diet period immediately 
preceding slaughter, the EPA and DHA content in the muscle are increased 
(Mráz, 2012; Rosenlund, 2001). 
To some degree, carnivorous fish species, such as salmon, are able to 
convert ALA into EPA and DHA. However, this conversion will most 
probably only try to meet the demands of the fish itself, leaving less EPA and 
DHA to meet the needs of human consumption. Consequently, if FO is 
substituted with VO significant decreases in the content of n-3 LCPUFA in the 
fish tissues will be observed (Sanden et al., 2011; Pettersson et al., 2009; 
Torstensen et al., 2005; Bell et al., 2001). This has also been seen in sea bass 
(Dicentrarchus labrax L.), where the flesh FA profile is impoverished in n-3 
PUFAs when fish were fed VO diets (Mourente et al., 2005), with a 
concomitant decrease of nutritional value. 
In terms of the consumer’s health, it would be beneficial to maintain as high 
as possible amounts of n-3 LCPUFA in fish muscle (Ackman, 1996). The 
inclusion of bioactive compounds to aqua feeds may serve to improve the FA 
profile of farmed fish.    
1.3.3 Bioactive compounds 
Bioactive compounds are naturally occurring constituents presented in small 
amounts in plant products and lipid rich foods providing health benefits beyond 
the basic nutritional value of the product (Kris-Etherton et al., 2002). Many of 
these substances affect the lipid metabolism and/or exhibit antioxidative 
properties. Low level of dietary antioxidants has been suggested to increase the 
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level of n-3 LCPUFAs in Atlantic salmon and salmon eggs (Bell et al., 2000; 
Pickova et al., 1998). A number of bioactive substances e.g. sesamin (S), 
episesamin (ES), tetradecylthioacetic acid (TTA) and lipoic acid (LPA) have 
been reported to affect lipid metabolism and/or FA composition in rainbow 
trout, Atlantic salmon and pacu (Piaractus mesopotamicus) (Trattner et al., 
2008a; Moya-Falcón et al., 2004).  
Sesamin 
Sesamin is an oil soluble lignan found in the sesame seed and oil. During the 
refining process of the sesame oil, ES is formed from S. Sesame lignans are 
well studied in mammals with significant effects on lipid metabolism. It has 
been shown to increase β-oxidation (Jeng & Hou, 2005; Ashakumary et al., 
1999) and affect elongation and desaturation of FAs in rats (Fujiyama-Fujiwara 
et al., 1995) and to lower serum levels of triacylglycerols and cholesterol in 
rats and humans (Jeng & Hou, 2005; Kushiro et al., 2002; Kamal-Eldin et al., 
2000). Enzymes involved in both the desaturation and β-oxidation of FAs are 
affected by S, both at the level of enzymatic activity and mRNA levels (e.g. 
acyl-CoA oxidase (ACO) and carnitine palmitoyl transferase 1 (CPT 1)) (Jeng 
& Hou, 2005; Kiso et al., 2005; Kushiro et al., 2002). Ide et al. (2001) also 
showed that S decreased the hepatic activity and mRNA expression of enzymes 
involved in FA synthesis. 
  Sesamin was shown to reduce Δ5 fatty acid desaturase (Δ5FAD) 
enzymatic activity in Mortierella alpina fungus and rat hepatocytes (Shimizu 
et al., 1991) but no similar effects could be detected on Δ5FAD mRNA levels 
in rats (Umeda-Sawada et al., 2003). The lipid modulating effects are possibly 
via the activation of peroxisome proliferator-activated receptors (PPARs) and 
inhibition of sterol regulatory element-binding protein-1 (SREBP-1) (Ide et al., 
2004; Ide et al., 2003; Ashakumary et al., 1999).  
Kushiro et al. (2002) showed that episesamin is more effective than sesamin 
in increasing the activity and gene expression of FA oxidation enzymes. In 
rats, S and ES are absorbed via the lymph and metabolized by the liver, and S 
has been reported to be metabolized faster than ES. Yasuda et al. (2012) 
showed a clear difference in metabolism between sesamin and episesamin in 
human liver microsomes by P450 (CYP2C9 and CYP1A2), UDP-
glucuronosyltransferase, and catechol-O-methyltransferase, resulting in 
different biological effects. 
Lipoic acid 
Another bioactive compound interesting for fish feed is lipoic acid (LPA), a 
naturally occurring thiol-compound with two sulfur atoms next to each other 
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connected through a disulfide bond. It is a potent antioxidant with one 
lipophilic and one lipofobic part, shown to have vitamin C and vitamin E 
sparing effects in mammals (Kozlov et al., 1999; Lykkesfeldt et al., 1998). 
LPA is synthesized in both mammals and plants within the mitochondria by 
lipoic acid synthase as a part of the de novo synthesis of FA (Hiltunen et al., 
2010b; Morikawa et al., 2001; Wada et al., 1997). LPA has also been shown to 
be active in the cellular energy metabolism playing part in the citric acid cycle 
(Bast & Haenen, 2003) as a covalently attached cofactor required for the 
activity of mitochondrial enzyme complexes (Wollin & Jones, 2003; Reed, 
1998). 
Huong and Ide (2008) were able to show that LPA decreased the PL and 
TAG concentrations in serum and liver of rodents. LPA was also capable of 
lowering the cholesterol concentration in mice serum (Yi & Maeda, 2006) and 
rat liver (Huong & Ide, 2008). A dose-dependent decrease of both the gene 
expression and activity of the lipogenic enzymes - fatty acid synthase, ATP-
citrate lyase, glucose 6-phosphate dehydrogenase, malic enzyme and pyruvate 
kinase was observed. Similar effect was also observed by the same group on 
the mRNA levels of other modulators of the fatty acid synthesis - spot 14, 
adiponutrin, stearoyl-CoA desaturase 1, and members of the elongation and 
desaturation cascade - Δ5FAD and Δ6FAD (Huong & Ide, 2008). 
LPA has been shown to affect the FA composition of fish muscle, towards 
higher levels of EPA (Trattner et al., 2007). 
Genistein 
Genistein (G) is a phytoestrogen, i.e., plant-derived compounds that possess 
estrogen-like biological activity. G is formed after hydrolysis of the isofavone 
genistin, which is found abundantly in soybean. G is known to exhibit 
antioxidative and hormone like effects (Yuan et al., 2007) and has therefore 
has been the subject of numerous studies for its possible beneficial and adverse 
health effects in humans and other mammals. G has been found to inhibit the 
oxidation of low-density lipoprotein (LDL) in human blood (Safari & Sheikh, 
2003) and enhance the expression of gene involved in the lipid catabolism 
through activation of carnitine palmitoyltransferase (CPT1) and PPARα (Kim 
et al., 2004). Studies on mice have shown that hepatic fatty acid synthase, β-
oxidation and CPT1 activities were all significantly lower in groups given 
genistein supplement (Ae Park et al., 2006).  
In vitro experiments have also shown that G binds and activates the three 
zebra fish estrogen receptors ERα, ERβ-A and ERβ-B and turn on the estrogen 
pathway (Sassi-Messai et al., 2009). G has also shown to inhibit hepatic and 
renal estrogen metabolism in rainbow trout (Oncorhyncus mykiss), Atlantic 
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salmon (Salmo salar L.), and lake trout (Salvelinus namaycush) (Ng et al., 
2006) and thereby increase the bioavailability of estradiol-17β.  
However, both in vitro and in vivo studies have shown that higher 
treatments with 0.25x10−4 M genistein had toxic effects on zebra fish embryos 
(Kim et al., 2009; Sassi-Messai et al., 2009) with retarded hatching times, 
malformations and increased mortality in a dose-dependent manner.  
1.4 Gene expression  
Gene expression as the word states deals with the difference in expression of 
genes as a response to external and/or internal stimuli of which daily 
environmental influences play a crucial role.  
The regulation of all processes from production through activation and 
deactivation to degradation of proteins involves at one point or another 
regulation of gene expression directly or indirectly.  
Simplified, the genetic information contained in the DNA is transcribed into 
a primary transcript (Precursor mRNA or pre-mRNA), which is further 
processed to produce a mature mRNA molecule within the nucleus (Figure 2) 
(Moore, 2005; Levine & Tjian, 2003).  
The pre-mRNA consists of a copy of the whole gene sequence, including 
both the exons, which code for the protein and introns, which are sections of 
non-coding DNA between the exons. The transformation into a mature RNA 
involves a splicing event, a 5’capping process and polyadenylation where 
introns are removed, the 5’-end is modified and adenine residues added to the 
3’-end of the mRNA. Hereafter, the mature mRNA is transported from the 
nucleus to the cytoplasm where it is translated to produce a protein according 
to the amino acid sequence encoded by first the gene and then the mRNA 
(Pandya-Jones, 2011; Moore, 2005).  
All mRNA contain both a coding sequence, which are translated to produce 
the appropriate protein, and untranslated sequences. These untranslated 
sequences/regions (UTRs) are present at both the 5’- and 3’-ends of the coding 
region. UTRs play a critical role in controlling gene expression through 
regulation of the polyadenylation, translation, stability and localization of the 
mRNA. The regulation occurs through the interaction of specific often rather 
short sequences that form secondary structures, such as bulges and stem-loops 
within the UTR with specific proteins (Barrett et al., 2012).  
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Figure 2 Schematic diagram over the critical stages from the transcription of a gene composed of 
7 exons, a 5’-untranslated region (5’UTR) and a 3’-untranslated region (3’UTR) until the mature 
mRNA is transported out of the nucleus to the cytoplasm. 
Theoretically, there are three possible outcomes for fully processed mRNA in 
the cytoplasm: they may be translated to produce protein, they may be 
immobilized or inactivated, and/or they may be degraded. 
In eukaryotes, the regulation of gene expression can occur at any step 
ranging from DNA–RNA transcription to post-translational modification of 
protein (Moore, 2005).  
The first regulation possibility occurs during the transcription where the 
chromatin arrangement and changes in DNA structure (epigenetic process 
including CpG methylation) influences accessibility of promoter sequences and 
the differential activity of transcription factors, determine whether or not genes 
are transcribed (Gräff et al., 2011; Schneider & Grosschedl, 2007).  
Additionally a verity of post-transcriptional regulation mechanisms such as 
the modulation of the activity of RNA binding proteins, alternative splicing, 
and presence of small non-coding RNAs triggering RNA interference are 
involved in modifying the stability and distribution of the mRNA ultimately 
affecting the outcome of the gene expression machinery (Moore, 2005; Bartel, 
2004; Ambros, 2001). 
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1.5 Molecular aspects of lipid metabolism in salmonids 
Lipids and FAs are together with proteins the major macronutrients in the diet 
of Atlantic salmon, constituting more than 30% of the diet (Leaver et al., 
2008a). Given the change in FA composition of salmonid feed from FO 
towards VO that is in progress, is it important to study the consequences on the 
underlying molecular mechanisms in both tissues and cells. Through oxidation 
the FAs can be used as energy source, or stored and deposited in adipose 
tissues (Tocher, 2003). All steps in the lipid metabolism from uptake to the 
conversion of LA and ALA in fish to ARA, EPA, and DHA as well as to the β-
oxidation are under nutritional regulation. In turn the dietary FAs act as 
regulators of gene transcription and consequently steer enzyme activity (Jump 
& Clarke, 1999; Hesketh et al., 1998).  
As a result hereof, the regulation of lipid homeostasis in Atlantic salmon is 
a complex balance between e.g. lipid uptake, transport, storage and 
biosynthesis. Each single one of these processes needs to be controlled 
independently as well as in co-junction with the other processes on both a 
tissue specific as well as whole body level (Tocher, 2003). As shown 
schematically in Figure 3 this can be reduced to two inter-linked processes; the 
influence of FA intake on gene expression and protein synthesis, and the 
influence of gene expression on FA requirements.  
 
Figure 3 Inter-relationship between fatty acid homeostasis and gene expression. 
FAs may alter the amount of functional protein expressed by a specific gene 
through a range of transcriptional, post-transcriptional and post-translational 
mechanisms. Dietary FAs are well known to have profound effect on gene 
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expression regulation. FAs and their metabolites can either indirectly influence 
the gene expression regulation by activating different transcription factors in 
the cytoplasm or directly by entering the nucleus by themselves or in 
association with ligand-activated transcription factors.  
1.5.1 Genomic background in salmonids 
Fish are the oldest and most diverse members of the vertebrates starting their 
evolution 540 million years ago (Powers, 1991). The salmonids genome is 
complex due to a fairly recent additional genome duplication that is believed to 
have occurred between 25 and 120 million years ago (Ohno, 1999; Allendorf & 
Utter, 1976).  
Tetraploidizations or genome duplications are important evolutionary 
events which most probably are responsible for the large increases in genome 
size and diversity early in vertebrate evolution (Ohno et al., 1968).  
At first, a duplication of a gene merely creates a redundancy. This acquired 
redundancy might present an advantage. However, if there is no immediate use 
for the duplicated gene, it will be allowed to drift without restraint or selective 
pressure. If this free drift does not result in the acquisition of a new, significant 
function by the duplicated gene, it is expected to degenerate (diploidization) 
(Ohno, 1999). In salmonids a large percentage of loci (50-75%) have remained 
as functioning duplicates and the diploidization process has not come to an end 
(Hordvik, 1998; Young et al., 1998; Allendorf, 1978; Bailey et al., 1978). 
Consequently, a specific locus in one species may still have four alleles, 
while in another species it may be converted to a pair of isoloci (e.g. pair of 
duplicated loci having gene products with identical constitution and 
electrophoretic mobility (Waples, 1988)). Accordingly, several gene duplicates 
have been cloned and described for salmonids (Morash et al., 2010; Evans et 
al., 2008; Leaver et al., 2007; McKay et al., 2004; Hordvik, 1998; Kavsan et 
al., 1993; Ohno et al., 1968) making it even harder to shed light over the 
intriguing gene regulation mechanisms in these species. 
1.5.2 Transcription factors 
A transcription factor is a protein that binds to specific DNA sequences within 
the promoter region, and by doing so controlling the transcription of genetic 
information from DNA to mRNA. This function is performed single-handedly 
or in a complex with other proteins, by promoting (as an activator), or blocking 
(as a repressor) the binding of RNA polymerase to specific promoter sequences 
(Latchman, 1997).  
It has been shown that dietary fat influence the gene expression by controlling 
the activity or abundance of central transcription factors (Jump et al., 2005). 
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Peroxisome proliferator activated receptors 
One nuclear receptor family that influences transcription according to 
nutritional state is the peroxisome proliferator-activated receptor (PPAR) 
family. PPARs are activated by ligands and respond to changes in lipid and 
glucose homeostasis in mammals (Jump et al., 2005). PUFAs are known to be 
one of these PPAR activating ligands. The ligand binding causes a 
dimerization of PPAR with the retinoid-X-receptor (RXR) forming a 
heterodimer (Figure 4). The PPAR–RXR complex activates target genes by 
recognizing promoter regions called peroxisome proliferator response elements 
(PPREs). The DNA consensus sequence for the PPRE is 
AGGTCAXAGGTCA, with X being a random nucleotide. If not activated, 
PPARs remain in the nucleus in a repressed state mediated by nuclear receptor 
co-repressors (Chinetti-Gbaguidi et al., 2005).  
 
Figure 4 Schematic overview of ligand-induced conformational change peroxisomal proliferator-
activated receptor (PPARs), translocation into the nucleus, dimerization with a retinoid-X-
receptor (RXR) and following binding to cis-regulatory elements in the promotor region of the 
target gene. 
PPARα has been shown to activate the gene coding for the β-oxidation 
enzyme, carnitine palmitoyltransferase 1 (CPT1) by binding to a peroxisome 
proliferator response elements  upstream in the promoter region of the gene, 
thereby playing an important role in regulating β-oxidation in rodents 
(McGarry & Brown, 1997), humans (Varanasi et al., 1996) and fish 
(Boukouvala et al., 2010). Similarly, PPARα also target genes coding for other 
β-oxidation enzymes ACO (Varanasi et al., 1996) and hydroxyacyl 
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dehydrogenase, fatty acid binding proteins and the transmembrane fatty acid 
transporters such as CD36 and FAT. Both PPARα and PPARγ have been 
shown to induce the transcription of the transmembrane fatty acid transporter, 
CD36 and SR-B1 (Burri et al., 2010; Poirier et al., 2001; Motojima et al., 
1998). 
All different subtypes have been identified in Atlantic salmon. Four genes 
coding for four different subtypes of PPARβ have been identified in Atlantic 
salmon. These subtypes were grouped into two families based on differences in 
exons and exon-flanking regions. Each subtype had a characteristic expression 
pattern varying between tissues (Leaver et al., 2007). Furthermore have two 
forms of PPARγ been described in Atlantic salmon liver (Andersen et al., 
2000; Ruyter et al., 1997). 
Sterol regulatory element-binding proteins 
Another group of key regulator of lipid and cholesterol metabolism is the sterol 
regulatory element-binding proteins (SREBP) that are attached to the nuclear 
envelope or bound endoplasmic reticulum (ER) (reviewed by Jump et al., 
2005). The FA levels, both intracellular and membrane levels are under 
constant supervision by SREBP and are coordinated with de novo lipid 
biosynthesis (Horton et al., 2002). SREBP belong to a family of transcription 
factors consisting of SREBP-1a, SREBP-1c, and SREBP-2 proteins that are 
encoded by two unique genes, Srebp-1 and Srebp-2 (Horton et al., 2002). The 
three SREBP regulate slightly different target genes and have different 
activation intensities as well as show different tissue specific expression 
patterns. SREBP-1c regulates the transcription of genes involved in FA 
metabolism, such as fatty acid synthase, SREBP-2 regulate both lipid 
homeostasis and cholesterol biosynthesis (Nakamura et al., 2004).  
Upon activation the inactivated membrane-bound SREBP is proteolytic 
released. When a specific cellular lipid level is low, the SREBP is transported 
to the Golgi, where it is processed by proteases to its active form. Afterwards 
SREBP is freed to move through the cytoplasm to the nucleus. In the nucleus, 
SREBP binds to the sterol regulatory element (SRE) DNA sequence that are 
found in the control regions of the genes that encode enzymes needed to make 
lipids. This binding to DNA leads to the increased transcription of the 
lipogenic target genes (Osborne & Espenshade, 2009). 
Taggart et al. (2008) and Leaver et al. (2008b) showed in Atlantic salmon, 
that SREBP-2 were upregulated when dietary FO was replaced with VO. 
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Liver X receptors  
Liver X receptors (LXR) are transcription factors whose activity is regulated 
by sterols. Equally, liver X receptor α (LXRα) and LXRβ have been shown to 
activate SREBP-1c in rodents (Cruz-Garcia et al., 2009; Zhou et al., 2008). 
However, high levels of unsaturated FAs activate LXR which in turn mediate a 
feed-back regulation on SREBP-1c, suppressing SREBP-1c transcription and 
consequently FA synthesis.  
The activated LXR induce cholesterol catabolism and de novo FA 
biosynthesis in liver through SREBP-1c, which has led to the suggestion that 
LXRs are sensors of the balance between cholesterol and FA metabolism. This 
has rendered a lot of focus on LXR and the gene coding for LXR has been 
cloned and characterized in several fish species besides salmonids (Cruz-
Garcia et al., 2009). 
1.5.3 Uptake & transport 
The liver is the crossing point for the exogenous and the endogenous transport 
of lipids. The most predominant mechanism in which lipids are taken up into 
the cells is through binding of lipoproteins to cell-surface trans-membrane 
lipoprotein receptors. Low-density lipoprotein receptor (LDL-R) and high-
density lipoprotein receptor scavenger receptor class B, type 1 (SR-B1) are 
among the most important lipoprotein receptors regulating the cholesterol 
levels in the plasma. 
Scavenger receptor class B, type I 
Scavenger receptor class B, type 1 (SR-B1) is a cell-surface, high-density 
lipoprotein receptor and a member of CD36 receptor family. SR-B1 is 
expressed in all tissues engaged in cholesterol metabolism (Rhainds & 
Brissette, 2004). Hepatic SR-BI has been shown to be negatively regulated by 
17β-estradiol (Sassi-Messai et al., 2009; Lopez & McLean, 2006). 
High levels of SR-B1 has been identified in the gut of Atlantic salmon 
which can indicate that SR-B1 has an important function in the uptake of lipids 
from the intestine (Kleveland et al., 2006b). Transcription factor SREBP has 
been shown to bind to the distal motif in the SR-B1 gene in both human and 
rodents and thereby inducing SR-B1 transcription (Rhainds & Brissette, 2004). 
PUFAs have been reported to increase hepatic cholesterol uptake, by activation 
of PPARα and/or PPARγ. PPARγ/RXR binds to a response element in the SR-
BI promoter which in turn induces the expression of SR-B1. Furthermore, 
hepatocyte nuclear factor 4α (HNF4α) was found to enhance PPARγ-mediated 
SR-BI transcription in rat hepatocytes (Malerød et al., 2003). 
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1.5.4 FA synthesis 
FAs in fish can arise from two sources. Either FAs can be synthesis de novo 
from non-lipid carbon sources, or directly from dietary lipid (Jump, 2011).  
De novo synthesis 
Acetyl-CoA derived mainly from protein can be converted to SFAs via the 
combined action of acetyl-CoA carboxylase and fatty acid synthetase (Hiltunen 
et al., 2010) in the mitochondria. The rate of FA de novo synthesis has been 
shown to be inversely correlated to the level of dietary lipids (Henderson, 
1996). 
Desaturation and Elongation 
The capacity of marine fish species varies in the ability to convert the 
vegetable C18 precursors LA and ALA to LCPUFAs. In freshwater species 
such as Atlantic salmon or rainbow trout, the desaturation/elongation pathway 
is under nutritional regulation. Thus, when these fish species are fed a diet 
lacking FO, they might possibly be able to modulate the activity of the 
enzymes to produce the LCPUFAs. 
The biosynthesis of LCPUFAs is similar in salmonids to that of other 
vertebrates (Cook & McMaster, 2002). The conversion of LA to ARA and 
ALA to EPA and DHA involves a chain of desaturation and elongation steps 
(Figure 5). The same enzymes catalyze the conversion of both n-6 and n-3 
fatty acid precursors into LCPUFAs. The two main enzyme families involved 
in these conversions are the elongases of very long fatty acids (ELOVL) and 
the fatty acyl desaturases (FAD)(Ruxton et al., 2005). The synthesis of DHA 
requires two additional elongation steps and a second Δ6 desaturation followed 
by a peroxisomal chain shortening (Sprecher, 2000) compared to EPA and 
ARA formation.  
Pawlosky et al. (2001) showed the rate-limiting step of the biosynthesis of 
LCPUFAs in healthy humans lays in the conversion of ALA to EPA (20:5n-3), 
whereas approximately 63% of all plasma EPA was accessible for production 
of 22:5n-3, and 37% of 22:5n-3 was available for synthesis of DHA (22:6n-3).  
Nakamura & Nara (2004) suggested these enzymes are regulated by a 
negative feedback loop and that an excessive intake of either LA, ALA, or any 
other PUFA can lead to a suppression of the PUFA synthesis. If the ratio of n-3 
to n-6 is not balanced at dietary intake, the excess of one type FA could 
suppress the conversion of the other PUFA group, increasing the imbalance 
even further. 
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Figure 5 Elongation and desaturation pathway of n-6 and n-3 fatty acids. Adapted from (Voss et 
al., 1991) and modified after (Trattner, 2009). 
Most marine fish are not able to convert PUFA to LCPUFA due to lack of one 
or more steps in the biosynthetic pathway as a result of relative deficiencies in 
one of the two enzymes in the desaturation and elongation cascade (Leaver et 
al., 2008a). However, fish that display a “freshwater pattern” like salmonids 
possess all the genes necessary for producing active Δ5FAD, Δ6FAD and 
ELOVLs, as well as the capacity to synthesize both n-3 and n-6 LCPUFAs 
(Zheng et al., 2009; Henderson, 1996). 
Our knowledge of the biomolecular mechanisms behind the LCPUFA 
biosynthesis in salmonids has increasing under the last two decades. Both 
Δ5FAD and Δ6FAD have been isolated and characterized in Atlantic salmon. 
Several studies have shown that both the genes and the biosynthesis of 
LCPUFA are upregulated in salmonids after VO feeding (Tocher et al., 2001). 
Highly conserved binding sites for the transcription factors SREBPs and NF-Y 
have been identified in the promoter region of the salmon Δ6FAD. In addition 
to these sites, a site was identified by Zheng et al. (2009) in salmon, which 
showed high similarity to a site that recognized by Sp1 transcription factor, and 
which was required for full expression of the salmon Δ6FAD gene. 
 Sesamin/episesamin and TTA have been shown to increase β-oxidation 
products and the levels of DHA in rainbow trout muscle (Trattner et al., 2008a) 
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as well affect the expression of Δ5FAD and Δ6FAD, CPT1, PPARα and 
PPARγ in Atlantic salmon hepatocytes (Trattner et al., 2008b).   
Low levels of dietary antioxidants have been suggested to increase the level 
of long chain n-3 FA in catfish (Ictalurus punctatus) (Baker & Davies, 1996) 
and in Atlantic salmon (Bell et al., 2000) as well as in salmon eggs (Pickova et 
al., 1998). LPA has been shown to increase the portion of EPA levels in pacu 
muscle (Trattner et al., 2007). 
Recently ELOVL4 has been isolated and characterised in Atlantic salmon. 
ELOVL4 has been shown to elongate C20 and C22 PUFA and to convert EPA 
and 22:5n-3 to 24:5n-3, an intermediate substrate for DHA biosynthesis 
(Carmona-Antoñanzas et al., 2011). 
 
1.5.5 β-oxidation 
The β-oxidation of FAs take place in both mitochondria and peroxisomes but 
the mitochondrial β-oxidation is quantitatively more important and can use a 
wide range of different FAs as substrate (Henderson, 1996). 
There are substrate preferences for SAFAs and MUFAs over PUFAs in the 
β-oxidation pathway. Both DHA and EPA are relatively spared from β-
oxidation when dietary levels of these FAs are low (Torstensen et al., 2004). 
Tocher et al. (2003) showed that changes in dietary oil type from FO to VO 
had no significant effect on β-oxidation in Atlantic salmon hepatocytes. 
The β-oxidation occurs in peroxisomes, when the FA chains are too long to 
be processed in the mitochondria but, the oxidation ceases at octanyl-CoA. It is 
proposed that very long chain (greater than C22) FAs undergo the initial 
oxidation in peroxisomes followed by final oxidation in mitochondria. ACO is 
the first and rate-limiting enzyme of peroxisomal β-oxidation (Varanasi et al., 
1996). 
The most significant difference for β-oxidation in the peroxisomes 
compared to the oxidation in the mitochondria is that peroxisomal β-oxidation 
is not coupled to any ATP synthesis. Additionally, peroxisomal β-oxidation 
requires enzymes specific to the peroxisome and to very long FAs.  
β-oxidation in the peroxisome starts with a rate-limiting step requiring the 
use of a peroxisomal carnitine acyl transferase for transport of the activated 
acyl group into the peroxisome instead of CPT1 and CPT2 used by the 
mitochondria (Pagot & Belin, 1996). 
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2 Objectives 
As Atlantic salmon is among the most popular fish species in our Western diet, 
the content of EPA and DHA within Atlantic salmon fillet as well as factors 
influencing these amounts are of importance. This thesis focuses on molecular 
regulation of the lipid metabolism in Atlantic salmon with the major emphasis 
given to LCPUFA biosynthesis.  
The anticipation is that understanding the molecular mechanisms will 
enable manipulation and optimization of the activity of desaturation and 
elongation of n-3 LCPUFA pathway to enable efficient and effective use of 
VO in aquaculture while maintaining the high nutritional quality from the wild 
catch fish. The long term objective for the research behind this thesis is to 
contribute to the development of diets adjusted for the individual fish species 
needs, a sustainable aquaculture as well as to an optimal use of LCPUFA. 
 
Specific objectives were to: 
 
 Study the effect of sesamin supplementation to VO based diets on the 
expression of genes related to FA metabolism and on the FA 
composition in Atlantic salmon after in vivo trails. (Paper I) 
 Study the effect of addition of lipoic acid, genistein, episesamin and 
sesamin to the culture media of Atlantic salmon hepatocytes in vitro on 
the expression of genes related to FA metabolism and if potential gene 
expression effects could be related to changes in the FA composition. 
(Paper II) 
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3 Material and methods  
In the section below a short description is given of the material and methods 
used in the studies included this thesis. More details on the specific procedures 
described, see Paper I-II.  
3.1 The design of the experimental series 
An overview of the material tested, specific methods, software and techniques 
used in the various studies is presented in Table 1.  
In Paper I, Atlantic salmon (Salmo salar L.) with an average final weight of 
554g were fed vegetable oil oil-based diets with different inclusions of 
sesamin. The diets used differed in n-6/n-3 fatty acid (FA) ratio (0.5 and 1) and 
sesamin content (high 5.8 g/kg, low 1.16 g/kg and no sesamin). The oils used 
in the feeds were a mixture of rapeseed, linseed and palm oil. Fish were fed for 
4 months. We evaluated the effects of sesamin supplementation on fatty acid 
composition and expression of hepatic genes involved in transcription, lipid 
uptake, desaturation, elongation and β-oxidation in liver as well as white 
muscle (Table 1). 
In Paper II, hepatocytes were isolated from Atlantic salmon (1300 g) 
according to the two-step collagenase procedure (Kjær et al., 2008; Dannevig 
& Berg, 1985; Seglen, 1976). The fish were kept in seawater at 10oC and fed a 
commercial diet prior to isolation of hepatocytes.  
The aim was here to evaluate the effects of bioactive compounds - the 
mixture of sesamin/episesamin, sesamin, lipoic acid and genistein, known to 
act as either antioxidants and/or influence lipid homeostasis in mammals. An 
array of gene expression assays was designed covering transcription factors 
and genes coding for proteins/enzymes involved in the lipid metabolism. The 
analyzed genes are listed in Table 1. Furthermore, the FA composition in 
Atlantic salmon hepatocytes was analyzed. 
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Table 1 Summary of experimental design and build up for Paper I – II 
Study No. I No. II 
Species Atlantic salmon Atlantic salmon 
Fish size 554g 1300g 
Samples b) Liver/White muscle Hepatocytes  
Sample size b) 1.7mg 1.7mg 
Number of replicates  6cd) 6d) 
Environmental conditions Seawater at 12°C Seawater at 10°C 
Control diete) Commercial Fish Feed Commercial Fish Feed 
Treatment Sesamin/Episesamin 
SH = 5.8 g/kg feed  
SL = 1.16 g/kg feed 
Lipoic acid 
Sesamin/Episesamin  
Genistein 
Vegetable oil dietf) V0.5 = 0.5 n-6/n-3 FA 
V1 = 1.0 n-6/n-3 FA 
 
Measurements Lipid analysis Lipid Analysis 
 Gene expression Gene expression 
Target genes PPARα, PPARβ1A, PPARγ, 
PGC-1, SREBP-1, SREBP-2, 
LXR, CD36, SP-B1, ELOVL2, 
ELOVL5a, ELOVL5b, 
∆5FAD, ∆6FAD, ELOVL4, 
ACO 
PPARα, PPARβ1A, PPARγ, 
CD36, ELOVL2, ELOVL5a, 
∆5FAD, ∆6FAD, ACO 
Housekeeping gene NUOR RPL2 
a) Liver, white muscle, red muscle, heart, brain, stomach, gills, intestine and kidney 
b) For the gene expression studies only 
c) Only liver was tested in gene expression experiments.  
d) All tests performed in triplicate 
e) All diets contained the recommended levels of vitamins and minerals 
f) Rapeseed, linseed and palm oil 
3.2 Lipid analysis 
The total lipid from diets, tissue, cells and the medium were extracted by using 
hexane:isopropanol (3:2 by vol.) (Hara & Radin, 1978).  
Total lipids of muscle tissue and liver were separated into triacylglycerols 
(TAG) and phospholipids (PL) on thin-layer-chromatography according to 
Pickova et al. (1997). The total lipids in the diets, and the triacylglycerols and 
phospholipids were methylated to fatty acid methyl esters following the 
method described by Appelqvist (1968) and analyzed with gas chromatography 
according to Trattner et al. (2008a) (Table 2). The peaks were identified by 
comparing their retention times with a standard mixture.  
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Table 2 Fatty acid composition (%) in experimental diet or media used in Papers I-II 
 Average control Paper I  Paper II 
 Fish oil Low n-6/n-3 High n-6/n-3 Culture media 
LA (18:2n-6) 3.20 14.6 15.3 3.70 
ALA (18:3n-3) 2.40 27.5 13.1 1.00 
ARA (20:4n-6) 0.40 0.10 0.10 2.40 
EPA (20:5n-3) 6.90 1.1 1.3 0.90 
DHA (22:6n-3) 9.70 1.6 1.8 1.20 
SAFA 24.8 17.5 18.8 40.7 
MUFA 41.5 34.0 47.0 22.3 
n-3 PUFA 23.3 30.9 16.9 3.60 
n-6 PUFA 6.20 15.4 15.9 6.90 
n-6/n-3 0.27 0.50 0.94 1.92 
SAFA saturated fatty acids (14:0, 16:0, 18:0); MUFA monounsaturated fatty acids (16:1n-7, 18:1n-9, 18:1n-7, 
20:1, 22:1); PUFA polyunsaturated fatty acids 
3.3 Gene expression analysis 
Gene expression in liver was investigated by quantitative Real-Time PCR 
using an array of target genes coding for enzymes involved in the lipid 
homeostasis.  
Total RNA was isolated using the spin purification method followed by 
DNase treatment. The total RNA was quantified and reverse transcription First 
strand cDNA was synthesized using the High-Capacity cDNA Archive kit.  
Real-time PCR analysis of the relative abundance of mRNA was assessed 
using Power or Fast SYBR®Green chemistry and gene specific primers 
designed using available Atlantic salmon sequences from the online version of 
GenBank®(NCBI) (Trattner et al., 2008b) using the Primer Express® software 
or copied from literature references. Primers for Real-time PCR analysis with 
corresponding Genbank accession numbers are listed in Table 3a-c. 
All samples were run simultaneously for each gene in triplicate with a non-
template control on each plate. A melt curve analysis was performed after each 
run to ensure that only a single product was amplified.  
Elongation factor 1a (EF1α), NADH-ubiquinone oxidoreductase (NUOR), 
Eukaryotic translation initiation factor 3 (ETiF) and RNA polymerase II 
polypeptide (RPL2) were evaluated for their stability across all experimental 
variables and samples thereafter the most stable reference gene  was chosen 
using the DataAssist software version 2.0. The ΔCT was calculated by 
subtracting the CT for the reference gene from the CT for the gene of interest. 
The relative expression was then calculated comparing the ΔCT values for fish 
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fed the different experimental diets with fish fed the standard fish oil diet using 
the term 2-ΔΔCT and reported as arbitrary fold change units (Livak & 
Schmittgen, 2001). 
3.4 Statistical analysis 
All data in the tables are presented as mean values ± standard deviation (SD). 
Difference between values were considered as significant when P ≤ 0.05. FAs 
were compared using the General Linear Model (GLM) in SAS statistical 
software. The model included the fixed effect of treatment and random effect 
of individual. Correlation tests were performed using Minitab 15 statistical 
software. Relative expression of the different genes, in relation to 
housekeeping genes were determined and mean values as well as SD were 
calculated using StepOne™ software version 2.2  and  DataAssist software 
version 2.0. The 95% confidence interval was calculated and used for statistical 
discrimination evaluation. 
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Table 3a. Sequences of primers used to amplify housekeeping genes and equivalent Genbank accession numbers used 
Primer Forward primer (5’-3’) Reverse primer (5’-3’) GenBank Acc. no 
RPL2a TAACGCCTGCCTCTTCACGTTGA ATGAGGGACCTTGTAGCCAGCAA CA049789 
EF1-αa CACCACCGGCCATCTGATCTACAA TCAGCAGCCTCCTTCTCGAACTTC AF321836 
NUORb CAACATAGGGATTGGAGAGCTGTACG TTCAGAGCCTCATCTTGCCTGCT DW532752 
ETiFc CAGGATGTTGTTGCTGGATGGG ACCCAACTGGGCAGGTCAAGA DW542195 
Abbreviations: RPL2 = RNA polymerase II polypeptide, EF1-α = Elongation factor 1α, NUOR = NADH-ubiquinone oxidoreductase, ETiF = Eukaryotic translation initiation factor 3. Already 
designed and validated in a) Jorgensen et al. (2006) b) Bahuaud et al. (2010) c) Castro et al. (2011) 
 
Table 4b. Sequences of primers used to amplify transcription factors and equivalent Genbank accession numbers used 
Primer Forward primer (5’-3’) Reverse primer (5’-3’) GenBank Acc. no 
PPARαa TCCTGGTGGCCTACGGATC CGTTGAATTTCATGGCGAACT DQ294237 
PPARβ1Ab GAGACGGTCAGGGAGCTCAC  CCAGCAACCCGTCCTTGTT AJ416953 
PPARγ (long/short) CATTGTCAGCCTGTCCAGAC ATGTGACATTCCCACAAGCA AJ292963 
PGC-1α CAACCACCTTGCCACTTCCT CGGTGATCCCTTGTGGTCAT FJ710605.1 
LXRe GCCGCCGCTATCTGAAATCTG CAATCCGGCAACCAATCTGTAGG FJ470290 
SREBP-1 GACAAGGTGGTCCAGTTGCT CACACGTTAGTCCGCATCAC NM001195818 
SREBP-2h TCGCGGCCTCCTGATGATT AGGGCTAGGTGACTGTTCTGG NM001195819 
Abbreviations: PPAR = Peroxisome proliferator-activated receptor, PGC-1α = Proliferator-activated receptor gamma coactivator 1 alpha, LXR = Liver X receptor α, SREBP = Sterol regulatory 
element binding protein. Already designed and validated in a)(Jorgensen et al., 2006) b)(Kleveland et al., 2006a) c)(Morais et al., 2009) d)(Trattner et al., 2008d) e)(Cruz-Garcia et al., 2009)  
f)(Bahuaud et al., 2010) g)(Castro et al., 2011) h)(Minghetti et al., 2011) i)(Carmona-Antoñanzas et al., 2011) 
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Table 5c. Sequences of primers and Genbank accession numbers used 
Primer Forward primer (5’-3’) Reverse primer (5’-3’) GenBank Acc. no 
CD36d GGATGAACTCCCTGCATGTGA TGAGGCCAAAGTACTCGTCGA AY606034  
Δ5FAD d GAGAGCTGGCACCGACAGAG GAGCTGCATTTTTCCCATGG AF478472 
Δ6FAD d AGAGCGTAGCTGACACAGCG TCCTCGGTTCTCTCTGCTCC AY458652 
ACOb CCTTCATTGTACCTCTCCGCA CATTTCAACCTCATCAAAGCCAA DQ364432 
CPT1d GTACCAGCCCCGATGCCTTCAT TCTCTGTGCGACCCTCTCGGAA AM230810 
SR-B1b AACTCAGTGAAGAGGCCAAACTTG TGCGGCGGTGATGATG DQ266043 
ELOVL5ac ACAAGACAGGAATCTCTTTCAGATTAA TCTGGGGTTACTGTGCTATAGTGTAC AY170327 
ELOVL5bc ACAAAAAGCCATGTTTATCTGAAAGA CACAGCCCCAGAGACCCACTT DW546112 
ELOVL2c CGGGTACAAAATGTGCTGGT TCTGTTTGCCGATAGCCATT TC91192 
ELOVL4i TTGTCAAATTGGTCCTGTGC TTAAAAGCCCTTTGGGATGA HM208347 
Abbreviations: CD 36 = cluster of differentiation 36, Δ5FAD = Δ5 desaturase, Δ6FAD = Δ6 desaturase, ACO = acyl-CoA oxidase, CPT1 = carnitine palmitoyl transferase I, SR-B1 =  Scavenger 
receptor class BI, ELOVL = Elongation of very long chain fatty acids gene. Already designed and validated in a)(Jorgensen et al., 2006) b)(Kleveland et al., 2006a) c)(Morais et al., 2009) 
d)(Trattner et al., 2008d) e)(Cruz-Garcia et al., 2009)  f)(Bahuaud et al., 2010) g)(Castro et al., 2011) h)(Minghetti et al., 2011) i)(Carmona-Antoñanzas et al., 2011)
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4 Summary of results 
4.1 Lipid analysis 
In Paper I the fat content in the white muscle was ~1.6% regardless of 
treatment, whereas the fat content in the liver increased significantly from ~5% 
to 7-8% in fish with the highest level of sesamin supplementation. 
The percentage of SAFA was significantly lower in both liver and white 
muscle samples from fish fed VO compared to fish fed FO in both the 
triacylglycerols (TAG) and phospholipids (PL) fractions. The relative amount 
of SAFA in both TAG and PL fractions of the liver and white muscle of fish 
fed FO were on average 23% and 26.5% respectively. The supplementation of 
sesamin to the VO diets decreased the amount of SAFA in the TAG fractions 
of both white muscle and liver (Table 4a) compared to a strait VO diet. In the 
liver the amount of SAFA was lowered in a dose dependent manner. The 
decrease was independent of the n-6/n-3 value in the diet fed to the fish. Of the 
individual SAFA 16:0 was most clearly affected by the addition of sesamin to 
the feed followed 18:0. The addition of bioactive compounds to the 
hepatocytes cell media did not affect the content of SAFA.  
The amount of MUFA in the PL fraction from white muscle and liver 
samples from fish fed FO diet are from 14.5% and 32.3%, respectively. The 
level of MUFA in the PL fraction of the liver was significantly decreased 
regardless of n-6/n-3 ratio and sesamin supplementation. Contradictorily, the 
MUFA content in the PL fractions of the white muscle was significantly 
increased regardless of n-6/n-3 ratio and sesamin supplementation. In the TAG 
fractions of both white muscle and liver in fish fed the diet with the higher n-
6/n-3 ratio, the amount of MUFA was at a significantly higher level compared 
to the control fish fed FO diets. Sesamin, when added to the feed, did 
significantly decrease the level of MUFA in the TAG fractions for the higher 
n-6/n-3 ratio group in both white muscle and liver. 
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Table 6a The effect of bioactive compounds on saturated (SAFA) and mono unsaturated fatty acid (MUFA) in the triacylglycerols and phospholipids fractions 
(% of total identified, mean value ± SD) of white muscle and liver from fish fed vegetable oil diet (Paper I) compared to fish feed fish oil based diet and in 
hepatocytes after incubation with respective treatment (Paper II) 
 Supplement 
Paper I Paper II 
Low n-6/n-3 High n-6/n-3 
Culture 
media 
triacylglycerols phospholipids triacylglycerols phospholipids 
white 
muscle liver 
white 
muscle liver 
white 
muscle liver 
white 
muscle liver 
SAFA control1) -7.8±0.8c -3.9±3.8b -5.1±0.1c 1.1±1.3 -7.0±0.2bc -5.7±1.5bc -3.2±0.5b -2.5±0.9b - 
 sesamin -7.7±0.5bc -6.5±1.8bcd -3.8±1.3bc 0.2±0.4 -6.9±0.2b -7.8±1.7cd -3.5±0.9b -3.3±0.8b -0.6±1.2 
 high sesamin -8.0±0.4c -7.4±1.6c -4.4±1.0b 0.3±1.4 -7.6±0.3bc -9.2±1.2c -2.9±0.8c 0.0±0.6 - 
 episesamin         0.1±1.43 
 lipoic acid         -0.5±0.43 
 low genistein          -0.5±0.75 
 high genistein         -0.1±0.79 
MUFA control1) -8.1±0.5d 3.1±3.7 2.4±0.9b -14.8±0.9c 4.5±0.2c 22.2±1.8c 5.9±0.7c -12.7±0.8c - 
 sesamin -7.8±0.3d 1.0±5.2 2.2±1.3b -14.6±0.7d 3.8±0.2bc 13.9±4.2b 6.1±0.8c -12.4±0.5bc   1.0±1.39 
 high sesamin -8.2±0.6d 5.2±2.6 2.4±0.8b -12.9±1.2c 3.6±0.3b 14.8±1.5b 5.9±1.4c -11.2±1.0b - 
 episesamin           0.6±1.26 
 lipoic acid         -1.5±2.88 
 low genistein            0.1±2.74 
 high genistein         -0.1±2.32 
1) Vegetable oil control diet without supplementation of bioactive compounds 
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The results are rather different in the TAG fraction for fish fed the low n-6/n-3 
diet. The amount of MUFA in the liver was the same as in fish fed the FO diet 
and no effect was seen with the addition of sesamin. This can be compared to 
the significant increase of MUFA in the corresponding TAG fraction in fish 
fed the high n-6/n-3 VO feed followed by a significant decrease with the 
addition of sesamin to the diet. 
In white muscle samples from fish fed the low n-6/n-3 diet, the amount of 
MUFA in the TAG fraction was significantly decreased compared to fish fed 
FO diet, but no increase or additional decrease was seen when sesamin was 
added. 
The amount of LA as well as ALA increase in TAG as well as PL fractions 
in both white muscle and liver samples from fish fed VO diets (Table 4b) 
regardless of n-6/n-3 ratio compared to fish fed FO diet. No effects were seen 
on the LA and ALA composition in Paper II after incubation of any of the 
bioactive compounds used. 
Looking at the changes in EPA and DPA in Table 4c, the amount of EPA 
increases in the liver of fish fed VO diet regardless of n-6/n-3 ratio both in the 
TAG and PL fractions. When sesamin is added to the feed the amount of EPA 
is increased significantly even further. In contrast, EPA decrease in the white 
muscle samples in all fish fed VO and no effect can be seen with addition of 
sesamin. 
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Table 7b The effect of bioactive compounds on the amount of LA (18:2n-6) and ALA (18:3n-3) in the triacylglycerols and phospholipids fractions (% of total 
identified, mean value ± SD) of white muscle and liver from fish fed vegetable oil diet (Paper I) compared to fish feed fish oil based diet and in hepatocytes after 
incubation with respective treatment (Paper II). 
 
Supplement 
Paper I Paper II 
Low n-6/n-3 High n-6/n-3 
Culture 
media 
triacylglycerols phospholipids triacylglycerols phospholipids 
white 
muscle liver 
white 
muscle liver 
white 
muscle liver 
white 
muscle liver 
LA 
(18:2n-6) 
control1) 8.7±0.2bcd 5.3±1.2c 4.7±0.8b 4.3±0.5d 8.4±0.4d 5.1±0.7c 6.6±0.4c 4.7±0.2cd - 
sesamin 8.5±0.2bc 6.8±1.0b 4.5±0.5b 5.0±0.5bc 8.5±0.2cd 6.1±0.9bc 6.4±0.4c 4.8±0.2bc 0.48±0.8 
high sesamin 8.8±0.2bc 6.1±0.9bc 4.8±0.4b 5.2±0.4bc 9.0±0.3b 6.2±0.8bc 6.5±0.7c 5.3±0.4b - 
episesamin         0.26±0.7 
lipoic acid         0.29±0.7 
low genistein          0.11±0.8 
high genistein         0.29±0.7 
ALA 
(18:3n-3) 
control1) 17.4±0.5b 8.52±1.8c 10.9±1.0b 3.52±0.9c 6.0±0.3c 2.71±1.8d 5.3±0.4c 1.27±0.8d - 
sesamin 17.0±0.6b 11.1±2.3b 10.3±0.9b 4.25±0.7b 5.9±0.1c 2.72±4.2d 5.0±0.4c 1.51±0.5d 0.53±0.6 
high sesamin 17.9±0.8b 9.82±1.4bc 10.3±1.1b 4.58±1.2b 6.4±0.5c 2.87±1.5d 5.1±0.6c 1.69±1.0d - 
episesamin         0.34±0.5 
lipoic acid         0.36±0.4 
low genistein          0.10±0.5 
high genistein         0.21±0.4 
1) Vegetable oil control diet without supplementation of bioactive compounds 
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Table 8c The effect of bioactive compounds on the amount of EPA (20:5n-3) and DHA (22:6n-3)in the triacylglycerols and phospholipids fractions (% of total 
identified, mean value ± SD) of white muscle and liver from fish fed vegetable oil diet (Paper I) compared to fish feed fish oil based diet and in hepatocytes after 
incubation with respective treatment (Paper II). 
 
Supplement 
Paper I Paper II 
Low n-6/n-3 High n-6/n-3 
Culture 
media 
triacylglycerols phospholipids triacylglycerols phospholipids 
white 
muscle liver 
white 
muscle liver 
white 
muscle liver 
white 
muscle liver 
EPA 
(20:5n-3) 
control1) -2.7±0.2c 5.3±1.2b -0.7±0.2b 4.3±0.5d -3.1±0.1d 5.1±0.7b -1.0±0.1c 4.7±0.2cd - 
sesamin -2.9±0.2cd 6.8±1.0c -0.9±0.5bc 5.0±0.5bc -3.0±0.1cd 6.1±0.9bc -1.0±0.1c 4.8±0.2bc 0.0±0.12 
high sesamin -3.1±0.2d 6.1±0.9bc -1.2±0.4cd 5.2±0.4bc -3.2±0.1d 6.2±0.8bc -1.3±0.1d 5.3±0.4b - 
episesamin         0.03±0.1 
lipoic acid         0.15±0.1 
low genistein          -0.03±0.2 
high genistein         0.05±0.1 
DHA 
(22:6n-3) 
control1) -8.3±0.2b -9.4±0.5bc -14.7±2.4b -11.4±2.3d -8.6±0.2b -9.3±0.4bc -15.7±1.0b -8.6±1.0bc - 
sesamin -8.2±0.2b -9.1±0.6b -14.1±1.4 b -10.4±0.8cd -8.5±0.2b -9.8±0.5bc -15.1±2.2b -9.3±0.8bc -1.30±1.0 
high sesamin -8.4±0.2b -10.1±0.2c -13.1±1.7b -12.2±1.7d -8.4±0.2b -9.9±0.7bc -14.2±2.0b -7.9±1.3b - 
episesamin         -1.00±0.8 
lipoic acid         0.70±2.2 
low genistein          -0.10±1.9 
high genistein         -0.50±2.2 
1) Vegetable oil control diet without supplementation of bioactive compounds 
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 4.2 Gene expression 
 
An overview of the relative changes in gene expression from Paper I and II are 
presented in Table 5.  
These results are normalized again a housekeeping gene selected on the 
basis that this gene was unaffected by any of the experimental parameters 
tested. A second round of normalization was the performed against the control 
treatment. The end data is presented as relative fold change compared to 
control. Here shown as series of minus and plus signs depending of if the gene 
expression was down- or upregulated, respectively. One minus or plus sign 
symbolizes the change of 1 magnitude compared to the results of the untreated 
control. 
In the in vivo experiment described in Paper I no clear significant effect 
were seen on PPARs, PGC-1 and LXR by sesamin addition. In fish fed the low 
n-6/n-3 ratio VO diet sesamin increased the expression of both ∆5FAD and 
∆6FAD. However when fed the high n-6/n-3 ratio VO diets the transcription of 
∆5FAD and ∆6FAD were down-regulated by sesamin. Both SREBP-1 and 
SREBP-2 expression increased by sesamin supplementation to the low n-6/n-3 
ratio VO diet. 
 The most pronounce effect of treatment with bioactive compounds in Paper 
II was seen on genes regulating the desaturation and elongation process of 
ALA and LA to EPA/DHA and ARA respectively.  
The effects of the different bioactive compounds were more apparent after 
48hr of incubation. In general sesamin, episesamin and lipoic acid increased 
the expression of ∆5FAD, ∆6FAD, ELOLV2, ELOLV5a, CD36, CPT-1 and 
ACO. Sesamin increased PPAR1β and γ and episesamin increased PPARα and 
1β. Incubation with lipoic acid for 12hr increased the expression of all PPAR, 
however further incubation for 48hr decreased the expression PPARα and 1β. 
During the same incubation period, lipoic acid significantly increased PPARγ 
transcription. 
 
42 
Table 5. The effect of bioactive compounds on the relative gene expression in liver from fish fed vegetable oil diet (Paper I) compared to fish feed fish oil based 
diet and in hepatocytes (Paper II) after incubation with respective treatment. Decrease in fold change shown here as minus signs and an increase in fold change 
shown as plus signs. One minus or plus sign equals to a change in fold change of one magnitude. In the grey areas no gene expression analysis was performed. 
   Gene Expression 
Paper 
 
Supplement 
Hours of 
incubation 
PPAR 
PGC-1 
SREBP 
LXR 
FAD ELOVL 
CD36 SP-B1 CPT1 ACO 
α β1 γ 1 2 ∆6 ∆5 2 5a 5b 4 
I 
 
Low  
n-6/n-3 
control1)     - - - -  -   ++ - -   +  
sesamin     - ++ +  +++ +++   ++ ++   +  
high sesamin   -  - +  + +++ +++  + + - -    +++ 
High  
n-6/n-3 
control1)     -    ++++ +++   + - - -  +  
sesamin      -   ++ ++    - -   ++  
high sesamin   - +          +    - 
II 
Culture 
media 
sesamin 12  + +      - 12+       ++ 
 48  ++ +++     ++ ++ +++ ++   ++  ++ +++ 
episesamin 12 +         11+       - 
 48 + +      + + + +   +++  +++ ++ 
lipoic acid 12 ++ ++ ++       10+    +  ++ +++ 
 48 - - +++++     + + ++++ +++   +  + +++ 
low genistein 12 ++++ ++ +      -       + ++ 
 48 -  -           -    
high genistein 12              +    
 48 - +                
1) Vegetable oil control diet without supplementation of bioactive compounds 
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5 General Discussion 
The main objective was to investigate the effect of the added bioactive 
compounds both in vivo and in vitro on the expression of genes related to lipid 
homeostasis in Atlantic salmon. Further we wanted to evaluate if the effect of 
sesamin supplementation was dependent of the underlying n-6/n-3 ratio of the 
VO diet.  
Our anticipation was to increase our understanding of the regulation of the 
molecular mechanisms for FA uptake, LCPUFA biosynthesis, mitochondrial 
and peroxisomal β-oxidation by investigating the effect of bioactive 
compounds.  
5.1 Effects on growth performance 
Replacement of FO with VO did not affect growth performance in Paper I, 
which is in accordance with results on Atlantic salmon (Torstensen et al., 
2005; Bell et al., 2001; Torstensen et al., 2000) and rainbow trout (Trattner et 
al., 2008a). However, did addition of sesamin have a dose-dependent negative 
effect on growth, but only the highest inclusion resulted in significantly 
reduced weight of the fish. This is in agreement with results obtained from 
trails with juvenile barramundi (Lates calcarifer), where the growth rate were 
reduced in fish receiving sesamin regardless of which dietary oil that were used 
in the feed (Alhazzaa et al., 2012). This is contradictory to results on growth 
performance in studies where the inclusion of sesamin in the feed was tested on 
Baltic Atlantic salmon (Trattner et al., 2011), rainbow trout (Trattner et al., 
2008a) and carp (Mraz et al., 2010). On the other hand, the reduced growth 
with the addition of  high sesamin content is in agreement with studies of other 
bioactive compounds e.g. dodecylthioacetic acid and tetradecylthioacetic acid 
(TTA) (Kleveland et al., 2006a), and Moya-Falcon et al. (2004) where these 
substances significantly lowered the body weight of Atlantic salmon.  
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5.2 Effects on lipid content 
5.2.1 Total lipid content 
In the in vivo study in Paper I with Atlantic salmon, the white muscle lipid 
content was not affected by sesamin supplementation. Liver fat content was 
however significantly increased by addition of the high level of sesamin, 
confirming previous findings in rats (Ashakumary et al., 1999). This is in 
contrary to results obtained by Moya-Falcón et al. (2004) where the liver lipid 
content was reported to be unaffected by the addition of TTA to Atlantic 
salmon diets. Equally did neither the addition of conjugated linoleic acid nor 
TTA  affect the total amount of lipids in liver of Atlantic cod (Kennedy et al., 
2007b). 
5.2.2 Fatty acid composition 
As expected, did the composition of FAs in white muscle and liver to a great 
extent mirror the FA composition in the different diets. For example was the 
amount of MUFA in the TAG fractions significantly higher in both white 
muscle and liver from fish fed the VO diet with the high n-6/n-3 compared to 
the control fish fed FO diets as a consequence of the significant higher amount 
of MUFA in the VO feed. Equally did the replacement of FO with VO reduce 
the proportion of DHA in both white muscle and liver. Increased levels of LA 
and ALA were also observed as an effect of VO inclusion compared with FO. 
These results are in agreement with those in the study of Bell et al. (2001), who 
found that replacement of FO with rapeseed oil (100%) lowered the proportion 
of DHA in both liver and muscle but to somewhat different degrees. 
In Paper I did the two different n-6/n-3 ratios have an impact on n-3 FA 
content in fish, mainly in that the higher ratio resulted in lower amounts of 
ALA. This decrease was not reflected in higher percentage of DHA and EPA. 
No effect of sesamin supplementation was seen on the amount of ALA 
(18:3n-3) in neither the TAG nor PL fractions of white muscle and liver 
samples. Equally did sesamin not cause any changes in the levels of ALA 
(18:3n-3) in the hepatocytes studied. This is conflict with results on studies 
with sesamin supplementation to juvenile Baltic Atlantic salmon, where a 
significant decrease of ALA (18:3n-3) in the white muscle PL fraction where 
seen together with a slight increase of DHA (22:6n-3) (Trattner et al., 2011). 
Sesamin did however affected FA involved in the synthesis of DHA, e.g. 
20:3n-3 increased, EPA and 22:5n-3 decreased and a slight increase in DHA 
was detected (non significant). In previous studies a significant increase in 
DHA was observed on addition of a dietary sesamin/episesamin mixture in 
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both white muscle of rainbow trout (Trattner et al., 2008a) and  in Atlantic 
salmon hepatocytes (Trattner et al., 2008b). 
In Paper II the gene expression results were not supported by the FA 
composition. Sesamin and episesamin treatments increased the proportion of 
18:4n-3 and 20:4n-3. Lipoic acid increased the proportions of 20:3n-3 and 
20:4n-3. After 48 h incubation with lipoic acid, episesamin or sesamin, an up 
regulation of all the genes chosen as markers (ELOVL5a, ∆5FAD, ELOVL2 
and ∆6FAD) for the biosynthesis of PUFAs were seen. Equally did the 
addition of Echium oil, rich in stearoidonic acid (18:4n-3) and γ-linoleic acid 
(18:3n-6), increase the expression of the ∆6FAD and elongase in barramundi 
tissues, but this did not lead to a significant accumulation of DHA, but both the 
amount EPA and ARA were increased  (Alhazzaa et al., 2011). The increased 
levels of intermediate FAs in the PUFA synthesis and the increased expression 
of involved genes support that these bioactive compounds might have an 
impact on the lipid metabolism. During the trial salmon hepatocytes incubated 
with G did not show any significant difference in FA composition compared to 
control incubations. In general the effects on FA profile were low and not as 
significant as the gene expression results.  
Environmental factors 
The difference in response to bioactive compounds compared to previously 
published results could be explained by several factors. First of all may the 
physiological response to sesamin vary dependent on fish size or species. 
Within the same species, variations in the response to sesamin may depend on 
age, gender and possibly environmental conditions such as temperature and 
feed composition.  
The feeding period can also affect physiological response to sesamin. In 
Paper I, the experimental diets were fed to fish for four months, which is 
longer than in previous studies (8-11 weeks) (Mraz et al., 2010; Trattner et al., 
2010; Trattner et al., 2008a). Furthermore, seawater fish have a lower capacity 
to convert ALA to DHA than freshwater fish (Sales, 2010; Zheng et al., 2004; 
Sargent & Tacon, 1999).  
In the in vivo study in Paper I, pure sesamin was used, whereas Trattner et 
al. (2011; 2008a) supplemented the fish diet with an equi-mixture of 
sesamin/episesamin for rainbow trout and Baltic Atlantic salmon. The same 
mixture was used in a study on Atlantic salmon hepatocytes (Trattner et al., 
2008b). It has previously been shown in mammals that episesamin might be 
more effective in modulating the activity of enzymes involved in lipid 
metabolism. Therefore, the presence of episesamin in the diet of fish may be 
important for modulation of FA composition. 
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In Paper II, the fish were feed commercial FO based diet before 
scarification and hepatocytes preparation. Commercial FO based is particularly 
high in n-3 LCPUFAs. The individual fish used in the experiment were equally 
well nourished and with a high fat content. 
In previous studies episesamin has been shown to be more potent than 
sesamin. In this study there were no clear difference between them, only in the 
case of CD36 and CPT1, the expression were more upregulated for episesamin 
than sesamin. The expression of PPARγ was higher in the sesamin treated 
cells. 
Genetic variation 
The amount of dietary n-3 LC-PUFA, EPA and DHA stored in white muscle is 
a trait that has been shown to be highly heritable in Atlantic salmon (Leaver et 
al., 2011). Morais et al. (2011) showed that it would be possible to identify 
individual fish as well as groups/families of fish that  respond differently to 
different VO diets depending on their genetic background. In principal does 
lean fish display a more pronounce effect in response to the substitution of FO 
with VO compared to fat fish.  
Since no data were present in regards of genetic background of the fish 
tested in Paper I and II, is it difficult to refer to any difference in specific 
genetic traits compared the tested fish in previously reported results. However, 
this factor cannot be overlooked as a possible candidate influencing the 
outcome of these supplementation studies. 
5.3 Effects on lipid related gene expression 
5.3.1 Transcription factors 
With a few exceptions was there very limited response to addition of bioactive 
compound on all transcription factors tested regardless of the bioactive 
compound was added to the feed as in Paper I or to the cell media as in Paper 
II.  
Peroxisome proliferator activated receptors 
Sesamin showed no effect on PPARα expression which is contradictory to the 
findings of Trattner et al. (2008b) that showed that the expression of PPARα 
was significantly down regulated in the liver of rainbow trout fed sesamin as a 
supplement to a mixed oil diet.  
In the case of PPARγlong in Paper I, significant upregulation was seen when 
sesamin was added to higher n-6/n-3 ratio diets, while for PPARβ1A sesamin 
decreased the mRNA expression level. This could indicate that the effect of 
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sesamin is not caused by ligand binding to the PPARs. Cloning analysis of the 
ligand binding regions of PPARα and PPARγ genes in Atlantic salmon have 
revealed that they contain additional amino acid residuals, which could suggest 
that the ligand binding properties in salmon PPARs can differ from those seen 
in rodents (Andersen et al., 2000). This could explain the deviation from 
findings in rodents (Ashakumary et al., 1999). 
After 12h incubation, PPARγ was upregulated in G 0.005mM, LPA and S 
treated cells. The upregulation of PPARγ remained in the LPA and S treated 
cells after 48h.  
Sterol regulatory element-binding proteins 
Expression of SREBP-1 and SREBP-2 was significantly increased by sesamin 
addition to the low n-6/n-3 ratio diets, and in fish fed these diets the SREBP 
target genes, desaturases and elongases were also significantly upregulated. It 
has been shown in liver hepatocytes of rodents that ELOVL5 elongase, ∆6FAD 
and ∆5FAD desaturase expression are regulated by both PPARα and SREBP-
1c (Qin et al., 2009; Matsuzaka et al., 2002). In agreement with this, the 
present study showed increased expression of SREBP, elongases and 
desaturases.  
Liver X receptors  
Fish fed the V0.5SL and V0.5SH diets showed increased expression of LXR 
compared with fish fed the V0.5S0 diet. This could indicate that S acts on 
SREBP-1c directly or indirectly by activation of LXR. The increased 
expression of LXR and SREBP can also be associated, since LXRα and LXRβ 
have been shown to activate SREBP-1c in rodents (Cruz-Garcia et al., 2009; 
Zhou et al., 2008).  
5.3.2 Uptake of fatty acids 
Since both PPARα and PPARγ have been shown to induce the transcription of 
CD36 and SR-B1 (Burri et al., 2010; Poirier et al., 2001; Motojima et al., 
1998), it was not surprising that the effects on these genes were limited. No 
effects were seen on SR-B1 in Paper I, which is in agreement with 
observations made by Kleveland et al (2006b), where no effect in SR-BI 
expression was seen in response to either oleic acid or the EPA and DHA. 
Only CD36 was significantly downregulated in tissues from fish fed the 
higher dietary ratio of n-6/n-3 with sesamin added. The gene CD36 is also 
regulated by PPARγ (Zhou et al., 2008), which are present in two forms, 
PPARγ long, expressed in liver and involved in the regulation of FA 
metabolism and PPARγ short suggested to be present in Atlantic salmon 
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adipocytes and involved in adipocyte differentiation (Todorčević et al., 2008; 
Vegusdal et al., 2003; Ruyter et al., 1997). The expression of CD36 follows 
the same expression pattern as PPARγ in all treatments after 48h. 
The expression of CD36 was upregulated after 48h of incubation with ES, S 
and LPA 12 and 48h. The gene, CD36 is involved in the uptake of lipids (Pohl 
et al., 2005), indicating that these three bioactive compounds possibly can 
increase the hepatic uptake of FA from the media. The effect of ES was twice 
as high as for S. This finding is in agreement with Kushiro et al. (2002), who 
reported more potent effects of episesamin than sesamin. The increased 
expression of CD36 could be triggered by the increased FA metabolism 
measured in this study, as increased expression of β-oxidation, desaturation 
and elongation markers or vice versa. 
The transcription factor PPARα has been shown to be a regulator of FA 
metabolism in mice, by inducting genes coding for CD36 (Burri et al., 2010; 
Poirier et al., 2001; Motojima et al., 1998). Similarly in this study the 
expression of PPARα was related to the expression of the long chain FA 
transporter, CD36 in LPA 12h, genistein 0.005mM 48h and episesamin 48h.  
5.3.3 Elongation and desaturation 
The transcription rate of all elongases except ELOVL5a was increased in the 
liver of salmon fed VO, irrespective of n-6/n-3 ratio, compared with that of fish 
fed a FO diet. This is in line with Morais et al. (2009) who reported that 
expression of ELOVL5b and ELOVL2, but not that of ELOVL5a, was 
significantly increased in both liver and intestine when Atlantic salmon were 
fed VO instead of FO. ELOVL5b codes for genes involved in the elongation of 
C18 to C20 PUFA and ELOVL2 for genes involved in the elongation of C20 to 
C22 (Morais et al., 2009; Hastings et al., 2004). The increase in ELOVL5b and 
ELOVL2 in fish fed the VO diet (V0.5) with low sesamin addition was 
accompanied by upregulation of SREBP-1c and a non significant increase in 
the amount of 20:3n-3 and DHA in both the TAG and the PL fractions.  
Expression of SREBP-1 and SREBP-2 was significantly increased by 
sesamin addition to the low n-6/n-3 ratio diets, and in fish fed these diets the 
SREBP target genes desaturases and elongases were also significantly 
upregulated. It has been shown in liver hepatocytes of rodents that ELOVL5 
elongase, ∆6FAD and ∆5FAD desaturase expression are regulated by both 
PPARα and SREBP-1c (Qin et al., 2009; Matsuzaka et al., 2002). In agreement 
with this, Paper II showed increased expression of SREBP, elongases and 
desaturases.  
Expression of desaturation and elongation genes increased significantly 
with addition of S. The effect of S seemed to be influenced by the n-6/n-3 ratio 
50 
in the feed. For the lower n-6/n-3 ratio S increased desaturation and elongation, 
while for the higher n-6/n-3 ratio S decreased both desaturation and elongation. 
This is similar to results reported by Trattner et al. (2008b). A possible 
interaction between feed FA composition and sesamin content could explain 
the different results between the groups in the present study.  
After 12h incubation ∆5FAD showed a significant downregulation in cells 
incubated G 0.005mM, LPA and S. However, the expression of both ∆6FAD 
and ∆5FAD, were upregulated by ES, S and LPA after 48h. There were 
striking and rapid changes in ∆5FAD gene expression from a pronounced 
downregulation to an upregulation in G 0.005mM, LPA and S. The 
upregulation of desaturases after 48h incubation are contradictory to results 
obtained by Trattner et al. (2008a), where downregulation of both ∆6FAD and 
∆5FAD were detected after incubation with S. However, the downregulation of 
the desaturases were seen in combination with an increased amount of radio-
labeled DHA synthesized from 14C 18:3n-3 (Trattner et al., 2008a). In the 
present study no significant effects were observed on DHA levels, but on 
18:4n-3 and 20:4n-3, possibly due to differences in size of fish. It has been 
shown that the synthesis of DHA decrease with size/age in Atlantic salmon 
(Zheng et al., 2004). Another explanation can be the nutritional status of the 
fish at the time of sampling. Possibly, the desaturase activity, the gene 
expression and consequently the response to treatment depend on how stout the 
individual fish was at the time of sampling. In the present study the fish were 
fatter than in the study by Trattner et al (2008a). For further studies a weight 
and length relation could be interesting and helpful to understand the 
metabolism of lipids. Furthermore, in the previous study radio-labeled FA was 
used, whereas in this study total FA were analyzed and some changes could be 
masked by the endogenous pool of FA.     
The expression of ELOVL2 was the most sensitive gene for the bioactive 
compounds tested in this study, in agreement with Morais et al. (2009), who 
suggested ELOVL2 to be more prominent in salmon in contrast to rats where 
ELOVL5 is the most sensitive to dietary changes. After 12h of incubation with 
LPA, ES or S the most pronounce effect was seen for ELOVL2 and were still 
upregulated after 48 h. ELOVL2 is involved in the elongation of 20 and 22 
carbon FA towards longer FA (Monroig et al., 2009).  
5.3.4 β-oxidation 
Markers for β-oxidation, CPT1 and ACO were upregulated after 48h of 
incubation with LPA, ES and S. Low concentrations of G also increased 
mRNA levels for β-oxidation markers after 12h. This is in agreement with our 
previous study, which shown increased levels of β-oxidation products after 
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addition of S to Atlantic salmon hepatocytes (Trattner et al., 2008a) and in 
studies on rodents (Jeng & Hou, 2005; Ashakumary et al., 1999). LPA is also 
suggested to increase of β-oxidation by increasing adipokine, which increases 
the amount of the phosphorylated form of adenosine monophosphate kinase 
(AMPK). Activation of AMPK stimulates phosphorylation of ACO and 
decreases the enzyme activity, which enhances FA oxidation through 
decreased hepatic concentration of malonyl-CoA, an inhibitor of CPT1 (Huong 
& Ide, 2008).  
Genistein has been shown to be effective in decreasing the activity of 
enzymes involved in fatty acid synthesis as well as increasing the activity of 
enzymes involved in β-oxidation in rodents (Takahashi et al., 2009). Our 
results with 12h incubation with genistein support previous results showing 
that genistein act in the same manner as fibrates, known agonists of PPARα 
both in vivo and in vitro studies ion rodents (Ricketts et al., 2005) and as a 
ligand for PPARγ (Dang et al., 2003). Further CPT1 which also is regulated by 
PPARs and coordinately is regulating hepatic fatty acid oxidation was 
identified in a genetic screen searching for soy- and isofavone-regulated 
mRNAs in rats consistently with our results (Iqbal et al., 2002). 
Earlier studies in rats (Jeng & Hou, 2005; Ashakumary et al., 1999) and in 
salmon hepatocytes (Trattner et al., 2008b) found that sesamin positively 
influenced the activity and gene expression of both ACO and CPT1, which are 
involved in peroxisomal and mitochondrial β-oxidation, respectively. In the 
low n-6/n-3 ratio groups we found similar results for ACO but not for CPT1. 
However, in our study both ACO and CPT1 were significantly downregulated 
after high sesamin addition in the high n-6/n-3 ratio diet. This might indicate 
that the n-6/n-3 ratio influenced the response of β-oxidation genes to sesamin.  
The transcription factor PPARα has been shown to be a regulator of FA 
metabolism in mice, by inducting genes coding CPT1 (Burri et al., 2010; 
Poirier et al., 2001; Motojima et al., 1998). In the hepatocyte study in Paper II, 
PPARα and CPT1 were significantly upregulated in G 0.005mM 12h, LPA 12h 
and ES 48h, indicating that PPARα trigger the expression of its target gene for 
mitochondrial β-oxidation. The expression of PPARα was related to the 
expression of the long chain FA transporter, CD36 in LPA 12h, G 0.005mM 
48h and ES 48h. After 12h incubation, PPARγ was upregulated in G 0.005mM, 
LPA and S treated cells. The upregulation of PPARγ remained in the LPA and 
S treated cells after 48h.  
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5.4 Lack of correlation between changes in lipid related gene 
expression and lipid content 
5.4.1 Genetic variation 
In view of the whole genome duplication event that occurred in salmonids 
(Allendorf, 1978), transcriptomic and gene expression studies are often very 
tricky to analyze as well as to compare due to the presence of duplicated and 
highly similar genes whose transcripts might be differentially regulated. 
The amount of dietary n-3 LC-PUFA, EPA and DHA stored in white 
muscle is a trait that has been shown to be highly heritable in Atlantic salmon 
(Leaver et al., 2011). Morais et al. (2011) showed that it would be possible to 
identify individual fish as well as groups/families of fish that  respond 
differently to different VO diets depending on their genetic background. In 
principal does lean fish display a more pronounce effect in response to the 
substitution of FO with VO compared to fat fish. The shift in diet mainly 
affects the expression of lipid and carbohydrate metabolism genes through 
their signaling pathways. In lean fish both PPARα and PPARβ were 
downregulated in response to the VO diet. This could not be seen in fat 
salmon. However, for another transcription factor, SREBP-1, the gene 
expression was clearly up-regulated in the case of fat fish but not in that of the 
lean salmon. When dietary FO was exchanged with VO, the LCPUFA 
biosynthesis was up-regulate in a genotype specific manner. In lean fish 
compared to fat fish ∆5FAD, ∆6FAD and ELOVL2 were significantly up-
regulated, which was reflected in liver FA composition.  
5.4.2 Negative feedback regulation 
The unlimited excess of n-3 HUFA in salmonid feed prior to the shift in dietary 
oils can possibly be the cause of the reduced capacity in salmonids to swiftly 
increase the synthesis of n-3 HUFA, when the oil in feed is changed from FO 
to VO. It is possible that the breaking point from a salmonid perspective where 
the amount of polyunsaturated n-3 FA is too low and there is an urgent need 
for de novo synthesis is not reached in the natural lifespan of the fish 
investigated so far.  
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 Figure 6 Schematic representation of a gene expression system subject to negative feedback 
regulation. Modified after (Zeron & Santillán, 2010) 
Negative feedback regulation at the transcriptional level (Figure 6) is one of 
the most common motifs in gene regulatory networks (Zeron & Santillán, 
2010).  Nakamura & Nara (2004) suggested ∆5FAD and ∆6FAD are regulated 
by a negative feedback loop and that an excessive intake of either LA, ALA, or 
any other type of PUFA can be a problem, leading to a suppression of the 
PUFA metabolic pathway. So if the ratio of n-3 to n-6 is not balanced at 
dietary intake, the excess of one type FA could suppress the conversion of the 
other fatty acid type, increasing the imbalance of the dietary ratio even further. 
In Paper II, the fish were feed commercial FO based diet before 
scarification and hepatocytes preparation. Commercial FO based is particularly 
high in n-3 LCPUFAs. The individual fish used in the experiment were equally 
well nourished and with a high fat content. Even though the amount of EPA 
and DHA was low in the culture media of the hepatocytes, it is likely that the 
feeding conditions prior to slaughter with high levels of both EPA and DHA 
could influence the potential positive effect of bioactive compounds on the 
process of desaturation, elongation and β-oxidation to DHA. 
In general, in Paper II our results suggest a time dependent response 
regardless of bioactive compounds added to the medium, with more 
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pronounced effects after 48h. However, the individual bioactive compounds 
generated different effects. One can speculate that the mRNA turnover is 
extremely sensitive towards dietary changes resulting in a constant fluctuation 
of mRNA levels. Such a fluctuation could indicate that mRNA analysis as the 
only measurement without regarding potential post-transcriptional regulation 
mechanisms, protein levels or enzyme activity measurements is difficult to 
evaluate and relate to biochemical responses.  
This is supported by the findings of Henderson & Sargent (1984) who 
showed that the peroxisomal β-oxidation is increased only when there was an 
imbalance between the amount of the MUFA 22:1 to PUFAs, a situation which 
is very unlikely to occur in natural fish diets as well as in standard FO diet. 
Furthermore did Tocher et al. (2003) prove that there is also a significant 
correlation between the activity of the LCPUFA biosynthetic pathway and 
dietary n-3 LCPUFA levels.  
PUFA suppress the expressions of lipogenetic genes, and induce expression 
of PPARs which simultaneously induce the transcription of genes encoding 
proteins of lipid oxidation and thermogenesis (Price et al., 2000). 
Thomassen et al. (2012 ) showed that when both EPA and DHA were added 
to the rapeseed oil diet, the total process of desaturation, elongations and β-
oxidation to DHA was significantly reduced (to about 50%) in Atlantic salmon. 
In vitro studies by the same group indicate that the inhibition is triggered by 
DHA and not by EPA accumulation. The inhibition occurred mainly at the ∆6 
desaturation step from 24:5n-3 to 24:6n-3, and at the second elongation step 
(ELOVL2) from 22:5n-3 to 24:5n-3. Gene expression measurements showed 
equally, a significant inhibition of Δ5FAD and Δ6FAD genes coupled with a 
slight inhibition of the gene coding for ELOVL2 by both FO diet as well as 
rape seed oil feed supplemented with both EPA and DHA.  
Moreover several studies have demonstrated that the expression of Δ6FAD 
mRNA was lower in liver of salmon fed FO compared to fish fed VO 
(Thomassen et al., 2012b; Moya-Falcón et al., 2005; Torstensen et al., 2004). 
By this one can postulate that FO actually suppresses the desaturation and 
elongation of LCPUFAs.  
I have in Figure 7 tried to summarize the different possibilities of regulation 
in the desaturation and elongation process of LCPUFAs. I would like to 
emphasis that most likely not only one but several regulation pathways are 
involved in the desaturation and elongation cascade. The first and traditional 
alternative for feedback inhibition (Figure 7 I.) is where high levels of the 
metabolite in this case DHA directly inhibit the transcription of DNA to 
mRNA with the decrease of mRNA expression as end result. If this mode of 
action was dominating the current situation we would expect a decrease in the 
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gene expression of either ∆5FAD, ∆6FAD, ELOVL5 or ELOVL2, followed 
later by a decrease in enzyme activity and finally a decrease in amount of 
DHA. 
 
Figure 7 Schematic representation of different possible negative feedback regulation mechanisms 
in fish rich in EPA and/or DHA. 
The second alternative is the post-transcriptional regulation or RNA silencing 
(Figure 7 II.). Here no inhibition can be seen on the mRNA level ultimately 
decreasing the amount of active enzymes. In some cases it can even be possible 
to see an increase in the mRNA expression. In step III (Figure 7 III.) the 
feedback mechanisms somehow inactivate either the ∆5FAD or ∆6FAD 
desaturase and/or ELOVL5 or ELOVL2 elongase generating no end product 
(DHA). Finally the feedback mechanism could target other target genes or 
genes coding for transcription factors with effects on that particular gene 
expression as primary effect e.g. decreases in the expression of PPAR or 
SREBP. 
5.4.3 Post-transcriptional regulation  
Post-transcriptional regulation is the control of gene expression at the RNA 
level after the transcription and before the translation of the gene. After being 
produced, the stability and distribution of the different transcripts is regulated 
56 
(post-transcriptional regulation) by means of RNA binding protein that controls 
the various steps and rates of the transcripts. These steps involve alternative 
splicing, RNA degradation, addition of poly(A) tail, processing, RNA editing 
and exportation from nucleus to the cytoplasm, removal of the 5-prime cap 
from mRNA and finally the regulation of the actual translation.  
During the last decades the picture of gene regulation has become still more 
complex with the discovery of and focus on epigenetic regulation. Four major 
components of epigenetic regulation are promoter methylation, histone 
modification, chromatin conformation changes, and altered expression of non-
coding RNAs, especially microRNAs (miRNAs). 
Andreassen et al. (2009) was to my knowledge first to indicate that the S. 
salar genome contained conserved 7-mers in the 3’UTRs identical to miRNA 
target sequences suggesting that miRNA and RNA silencing also play a role in 
controlling protein expression in S. salar.  
The divergences between increases in gene expression of target genes in the 
desaturation and elongation cascade and the actual lack of response in FA 
content of EPA and DHA are most likely a result of a combination of feedback 
regulation and post-transcriptional regulation such as RNA silencing. This still 
needs to be verified. 
The lack of correlation between desaturase expression and LCPUFA 
biosynthesis may also indicate that the effect of sesamin was mediated through 
other mechanisms not yet understood.  
Several studies have shown that the enzymes and the genes involved in the 
biosynthesis of highly unsaturated FA are upregulated after VO feeding (Zheng 
et al., 2005; Tocher et al., 2001a). In our study, even though the results were 
not consistent, gene expression of the desaturases tended to be upregulated for 
fish fed the high n-6/n-3 VO diet, but the supplementation of sesamin 
decreased this upregulation somewhat even though the net gene expression was 
increased compared to fish fed FO. This is in agreement with findings reported 
for Atlantic salmon hepatocytes (Trattner et al., 2008b). In fish fed the low n-
6/n-3 VO diet sesamin significantly increased the gene expression of both 
∆5FAD and ∆6FAD. VO feeding decreased the actual amount of DHA in the 
fish fillet and the sesamin inclusion did not have any clear significant effect.  
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6 Main findings and conclusions 
In conclusion, we could demonstrate that it is possible to interact with the 
metabolism of lipids by addition of bioactive compounds. Lipoic acid, sesamin 
and episesamin showed more effects than genistein on gene expression. These 
three compounds also exerted some changes of FAs, whereas genistein did not. 
The few changes in FA composition, compared to our previous studies suggest 
that nutritional background and life stage of the fish interfere with the 
metabolism of lipids in cell cultures of primary hepatocytes.  
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7 Future perspectives 
The perspective for future studies is to continue research towards sustainable 
aquaculture with the main goal to find suitable replacements of fish oil in fish 
diets.  
 
Some specific areas of future interest are: 
 
 To study the ability of different fish families and species to metabolize EPA 
and DHA. 
 To study the relation of gene expression and protein expression after 
addition of bioactive compounds or changed lipid sources. 
 To study the post transcriptional regulation and possible interactions with 
lipid metabolism.  
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